Incyte to Report Fourth Quarter and Year-End 2023 Financial Results
23 Enero 2024 - 7:00AM
Business Wire
Incyte (Nasdaq:INCY) announced today that it has scheduled its
fourth quarter and year-end 2023 financial results conference call
and webcast for 8:00 a.m. ET on Tuesday, February 13, 2024.
The schedule for the press release and conference call/webcast
is as follows:
- Q4 & YE 2023 Press Release: February 13, 2024 at 7:00 a.m.
ET
- Q4 & YE 2023 Conference Call: February 13, 2024 at 8:00
a.m. ET
- Domestic Dial-In Number: 877-407-3042
- International Dial-In Number: 201-389-0864
- Conference ID Number: 13744020
If you are unable to participate, a replay of the conference
call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and the dial-in number for
international callers is 201-612-7415. To access the replay
you will need the conference ID number 13744020.
The live webcast with slides can be accessed at
Investor.Incyte.com and will be available for replay for ninety
days.
About Incyte
A global biopharmaceutical company on a mission to Solve On.,
Incyte follows the science to find solutions for patients with
unmet medical needs. Through the discovery, development and
commercialization of proprietary therapeutics, Incyte has
established a portfolio of first-in-class medicines for patients
and a strong pipeline of products in Oncology and Inflammation
& Autoimmunity. Headquartered in Wilmington, Delaware, Incyte
has operations in North America, Europe and Asia.
For additional information on Incyte, please visit Incyte.com or
follow us on social media: LinkedIn, Twitter, Instagram, Facebook,
YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240123747153/en/
Incyte Contacts Media
media@incyte.com
Investors ir@incyte.com
Incyte (NASDAQ:INCY)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Incyte (NASDAQ:INCY)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024